Real-world effectiveness of fremanezumab in patients with migraine switching from another mAb targeting the CGRP pathway: a subgroup analysis of the Finesse Study

202339 citationsJournal Articlegold Open Access

Authors

FINESSE Study is registered on the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (EUPAS44606).

Good health and well-being

Published in: The Journal of Headache and Pain

Volume 24, Issue 1, pp. 59-59

Field-Weighted Citation Impact: 8.79